✦ LIBER ✦

Effect of 24 weeks of treatment with epalrestat, an aldose reductase inhibitor, on peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

✍ Scribed by Kenzo Uchida; Toshikazu Kigoshi; Shigeru Nakano; Takashi Ishii; Mitsutaka Kitazawa; Shinpei Morimoto

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of epalrestat, an aldose reducta

✍ Toshihide Kawai; Izumi Takei; Mikiya Tokui; Osamu Funae; Kazunori Miyamoto; Mits 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 434 KB

Long-term effect of epalrestat on cardia

✍ Tadasu Ikeda; Keiko Iwata; Yasushi Tanaka 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Natural History of Peripheral Neuropathy

✍ Partanen, Juhani; Niskanen, Leo; Lehtinen, Juha; Mervaala, Esa; Siitonen, Onni; 📂 Article 📅 1995 🏛 Massachusetts Medical Society 🌐 English ⚖ 99 KB

The effect of an aldose reductase inhibi

✍ Roy, Thomas M.; Broadstone, Vasti L.; Peterson, Hugh R.; Snider, Harvy L.; Cyrus 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 657 KB

Effects of aldose reductase inhibitor an

✍ Keita Utsunomiya; Isamu Narabayashi; Koji Tamura; Yuko Nakatani; Yoshinori Saika 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 77 KB

Correlation of acetylator phenotype with

✍ A. Misra; V. Mittal; S. Jain; J. S. Bajaj 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 95 KB